The effect of adrenergic blocking agents (including chlorpromazine) on serum lipid levels of patients with disorders of fat metabolism.
D018674:Adrenergic Antagonists; D002746:Chlorpromazine; D006801:Humans; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood*; D013566:Sympathomimetics
D018674:Adrenergic Antagonists; D008055:Lipids; D013566:Sympathomimetics; D002746:Chlorpromazine
LIPIDS/in blood; SYMPATHOMIMETICS/effects